Manufacturers of OTC monograph drugs got more than a more efficient program controlling how their products are formulated and labeled under the Coronavirus Aid, Relief and Economic Security (CARES) Act Congress passed in 2020.
They, along with firms making homeopathics marketed in the US without pre-market approval and makers of some approved drugs, also...